Informed consent: Old and new challenges in the context of the COVID-19 pandemic

  • Erin Rothwell
  • , Donna Brassil
  • , Marietta Barton-Baxter
  • , Kimberly A. Brownley
  • , Neal W. Dickert
  • , Daniel E. Ford
  • , Stephanie A. Kraft
  • , Jennifer B. McCormick
  • , Benjamin S. Wilfond

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future research and public health crises. The experiences and challenges for CTSA institutions offer an important perspective for examining what we have learned about informed consent and determining the next steps for improving the consent process.

Original languageEnglish (US)
Article numbere105
JournalJournal of Clinical and Translational Science
Volume5
Issue number1
DOIs
StatePublished - 2021

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Informed consent: Old and new challenges in the context of the COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this